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Abstract
Purpose: The aim of this work was to develop a mapping algorithm for estimating EuroQoL 5 Dimension (EQ-5D)
utilities from responses to the Long-Term Conditions Questionnaire (LTCQ), thus increasing LTCQ’s potential as a
comprehensive outcome measure for evaluating integrated care initiatives.
Methods: We combined data from three studies to give a total sample of 1334 responses. In each of the
three datasets, we randomly selected 75% of the sample and combined the selected random samples to
generate the estimation dataset, which consisted of 1001 patients. The unselected 25% observations from
each dataset were combined to generate an internal validation dataset of 333 patients. We used direct
mapping models by regressing responses to the LTCQ-8 directly onto EQ-5D-5L and EQ-5D-3L utilities as well
as response (or indirect) mapping to predict the response level that patients selected for each of the five EQ-
5D-5L domains. Several models were proposed and compared on mean squared error and mean absolute
error.
Results: A two-part model with OLS was the best performing based on the mean squared error (0.038) and
mean absolute error (0.147) when estimating the EQ-5D-5L utilities. A multinomial response mapping model
using LTCQ-8 responses was used to predict EQ-5D-5L responses levels.
Conclusions: This study provides a mapping algorithm for estimating EQ-5D utilities from LTCQ responses.
The results from this study can help broaden the applicability of the LTCQ by producing utility values for use
in economic analyses.
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Introduction
In the global context of ageing populations who are
likely to experience multi-morbidity, there is an in-
creasing drive towards integrated models of care that
bring together formal health services, social care
provision, and community-based services to support
local population needs [1, 2]. The dual aims of inte-
grated care are to implement a person-centred ap-
proach for supporting people with complex care
needs, and to ensure the sustainability of health sys-
tems over the long term. Economic evidence is an es-
sential component of integrated care evaluation, but
the evidence must be relevant to all involved stake-
holders. For example in England, the economic im-
pacts of integrated care initiatives (including pooled
budgets) between Clinical Commissioning Groups re-
sponsible for health care planning and Local Author-
ities responsible for social care provision need to be
assessed via outcomes relevant for both health and
social care (e.g. well-being, independence).
Most existing outcome measures for economic evalu-
ation, such as the EQ-5D [3], are based on the construct
of Health-Related Quality of Life (HRQoL). HRQoL fo-
cuses mainly on functional status and symptom burden,
for example the extent to which someone is physically
mobile or experiences depression. Research highlights
the limitations of this for understanding what matters to
those living with long term conditions [4, 5]. Alterna-
tively, Social Care Related Quality of Life (SCRQoL), as
measured by the Adult Social Care Outcomes Toolkit
(ASCOT) [6], focuses on wider aspects of well-being
such as safety, personal comfort, and social participation.
However, HRQoL and SCRQoL are each arguably too
narrow for evaluating integrated health and social care
interventions, which will simultaneously seek to minim-
ise symptom burden (and associated use of health re-
sources) and to maximise the efficacy of social support
for ‘living well’ in its broadest sense.
The Long-Term Conditions Questionnaire (LTCQ) is
a 20-item patient-reported outcome measure (PROM)
designed to measure ‘living well with long-term condi-
tions’ across health and social care domains. It enables
patients to self-report on the overall impact of living
with one or multiple long-term conditions (LTCs), in-
cluding physical and/or mental health conditions of
varying severity. LTCQ was initially validated amongst a
diverse sample of health and social care users in England
[7], demonstrating strong psychometric properties of in-
ternal consistency, construct validity, and test-retest reli-
ability. It has since been validated for use in memory
clinics by patients with mild cognitive impairment or de-
mentia [8], and it is being used to evaluate clinical inter-
ventions for schizophrenia [9]. LTCQ’s person-centred
construct of ‘living well’ captures outcomes that are
relevant for integrated care initiatives, e.g. sense of con-
trol over daily life, safety, confidence to self-manage ill-
ness. Further psychometric analysis using Rasch
modelling was undertaken to identify 8 candidate items
for a Short-Form LTCQ (LTCQ-8), which correlates
strongly with the 20-item version and maintains unidi-
mensionality of its core construct [10].
The Social Care Institute for Excellence in the United
Kingdom advocates three types of outcomes for evaluat-
ing integrated care: personal improvement of health and
well-being (measured by PROMs), service improvement
of care quality (measured by patient experience mea-
sures and process indicators), and value and sustainabil-
ity of the system (e.g. cost-effectiveness and timely
delivery of services to those in greatest need) [11]. A
generic PROM such as EQ-5D is advantageous for its
concurrent use in quality-of-life and cost-effectiveness
analyses - the EQ-5D remains the National Institute for
Clinical and Care Excellence’s (NICE) preferred measure
of health-related quality of life [12] - but it is conceptu-
ally limited in capturing outcomes of importance for in-
tegrated care. The content of LTCQ is potentially more
appropriate in this context, but LTCQ currently has no
associated utility values for economic analyses. The aim
of this work was to develop a mapping algorithm for es-
timating EQ-5D utilities from LTCQ-8 responses, thus
increasing LTCQ’s potential as a comprehensive out-
come measure for evaluating integrated care initiatives.
Methods
This mapping study has been conducted following the
MAPS (MApping onto Preference-based measures
reporting Standards) statement [13]. The approach was
also informed by ISPOR guidance on mapping from
non-preference based outcome measures [14]. The valu-
ation of the EQ-5D-5L was based on the UK value set
[15] and the cross-walk to derive EQ-5D-3L utilities [16]
following the latest position of National Institute for
Health and Care Excellence (NICE) [12].
Datasets
Three different datasets were used in this study. The
first dataset was derived from the validation study of the
LTCQ, where 1211 patients with at least one of 11 speci-
fied LTCs (cancer, chronic back pain, COPD, diabetes,
depression, irritable bowel syndrome, ischemic heart dis-
ease, multiple sclerosis, osteoarthritis, severe mental
health conditions including schizophrenia, stroke) were
recruited from geographically diverse regions in England
representing urban and rural communities, as well as
areas of high and low deprivation [7]. Approximately
three-quarters of the participants (health care cohort)
were recruited through 15 primary care (GP) practices
in 3 regions (South East, North West, Yorkshire and
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Humber), and the remaining quarter (social care co-
hort) were recruited through 4 Local Authorities (in
North West, East of England, South West, and
Greater London). In addition to the 20-item LTCQ
participants completed several established PROMs in-
cluding the EQ-5D (5-level version), the Disease Bur-
den Impact Scale (DBIS) through which participants
indicated the name and perceived impact of each
long-term condition that they had, and a range of
demographic questions [17]. The version of the DBIS
used allows for up to 25 LTCs to be reported, each
on an impact scale from 0 (does not have the condi-
tion) to 5 (high daily impact of the condition), for a
theoretical maximum impact score of 125. From the
1211 participants, 37 were removed from the mapping
study because of missing observations in the EQ-5D-
5L questionnaire and 48 patients due to missing ob-
servations in LTCQ responses, leaving 1126 patients
included in the estimation data set.
The second dataset (n = 115) included the baseline
data from the Feeling Safe Study, a randomised con-
trolled trial of a psychological intervention that recruited
people with schizophrenia in South East England (Oxford-
shire, Northamptonshire, and Berkshire) between February
2016 and July 2019 [9]. Three patients were excluded from
the 118 patients in the Feeling Safe Study dataset because
of missing LTCQ items. The third dataset (n = 93)
stemmed from further validation work to test LTCQ’s psy-
chometric properties amongst people with cognitive im-
pairment, who were minimally represented in the original
validation study. From the 102 respondents with dementia
or mild cognitive impairment recruited in 14 memory
clinics in South East England between February and August
2018, 9 were excluded because of missing observations in
EQ-5D-5L and/or LTCQ.
In all three datasets, participants completed the full
20-item LTCQ. Responses for the 8 short-form items
were extracted for the analyses below. A reduced num-
ber of LTCQ items facilitated model convergence, and
these items were identified through modern psychometric
methods as the best-performing, conceptually independ-
ent items for representing LTCQ’s general construct of
‘living well with long-term conditions’ [10]. As LTCQ-8
may be used as a stand-alone measure for larger-scale
studies in the future, we based the mapping models on
these items only (Table 1).
Estimation dataset and internal validation
In the LTCQ validation sample, only 7% of respondents
reported a severe mental health condition, and only 9
respondents reported dementia. Considering that the
LTCQ is an instrument for all long-term conditions, in-
cluding mental health conditions and dementia, we com-
bined the three datasets to ensure that the estimation
and validation samples for EQ-5D utilities mapping were
representative of the wider LTCQ population. The inclu-
sion of the mental health dataset allowed us to map
LTCQ to low EQ-5D utilities, taking account of the
major impact that severe mental conditions such as
schizophrenia have on HRQoL [18, 19]. The dementia
dataset was included in the estimation dataset to include
the utilities of older people with affected memory prob-
lems and complex needs.
In each of the three datasets, we randomly selected
75% of the sample and combined the selected random
samples to generate the estimation dataset, which con-
sisted of 1001 patients (845 from LTCQ, 86 from men-
tal health, 70 from dementia). The unselected 25%
observations from each dataset were combined to gener-
ate an internal validation dataset of 333 patients.
Statistical analysis
We used direct mapping models by regressing responses
to the LTCQ-8 directly onto EQ-5D-5L and EQ-5D-3L
utilities as well as response (or indirect) mapping to pre-
dict the response level that patients selected for each of
the five EQ-5D-5L domains. The predictor variables in
each fitted model were 32 dummy variables indicating
whether or not a patient had a particular response on each
LTCQ-8 question. We performed a complete case analysis
because imputation introduces an additional source of
error that can affect the precision of the algorithms [20].
Considering also the low missing data (i.e. 3%) in the esti-
mation dataset, imputation was unlikely to affect the com-
parison of the mapping models. No patient characteristics
(e.g. gender) were added as covariates in the best perform-
ing model because missing observations could reduce pre-
diction accuracy. We also wanted to ensure that the
mapping algorithm can be applied to datasets that do not
include patient characteristics. All statistical analyses were
performed in STATA version 15.
Direct mapping models
Ordinary least square (OLS) regression is the most fre-
quently used mapping method [21]. However, several
Table 1 The LTCQ-8 questionnaire
The 8 items of LTCQ-8
4. Felt in control of daily life
7. Felt safe at home
8. Felt safe outside the home
10. Felt more dependent on others than you wanted
11. Felt lonely due to health conditions
12. Worried about being treated differently
15. Felt that your health conditions made you unhappy
19. Felt confident in managing health conditions
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theoretical limitations have been highlighted in the context
of HRQoL data [22]. Most particularly the assumption
under OLS that the data is continuously distributed means
the likelihood of having being in full health, a value of 1, is
low, whereas in practice this is a relatively common re-
sponse (10% of all responses considered in this study report
perfect health). Despite this, recent work has shown that
OLS performs well in mean prediction [23]. Tobit models
have been used in EQ-5D mapping studies as an alternative
to OLS to better deal with the bounded nature of EQ-5D
utilities [24, 25]. Thus, the lower and upper limits for a
Tobit model were specified as the minimum and maximum
possible score on the EQ-5D-5L scale (i.e. -0.285 and 1 re-
spectively) and on the EQ-5D-3L scale (i.e. -0.594 and 1 re-
spectively). In the presence of heteroscedasticity, non-
normality, and censoring, censored least absolute deviations
(CLAD) models provide consistent estimates [23] and thus,
it has been used extensively in HRQoL mapping literature
[21, 26]. The limits and dependent variable in this model
were specified as in the Tobit model. The observed EQ-5D-
5L utility was used as the dependent variable in the OLS,
Tobit and CLAD models.
Generalised Linear Model (GLM) allows for the skewed
distribution of EQ-5D utility data and prevents prediction
of utilities higher than 1 [27]. We specified two GLMs,
one with Gamma family and log link and another with
Gaussian family and log link, to predict EQ-5D-5L disutil-
ity. To fit these models, the dependent variable was trans-
formed as 1 −Utility. Furthermore, fractional logistic
regression was used to constrain utility predictions be-
tween − 0.281 and 1 for EQ-5D-5L utilities, and between
− 0.594 and 1 for EQ-5D-3L utilities. The dependent vari-
able in the regression with the EQ-5D-5L utility was
Utility0 − 1 ¼ Utilityþ 0:285ð Þ=1:285 ð1Þ
Two-part models have been used in utility mapping
studies to allow for a relatively large proportion of ob-
servations reporting perfect health on EQ-5D (i.e. utility
of 1) [22]. We therefore, specified two two-part models.
In the first part of these models, a logistic regression was
used to estimate the probability an individual to report
perfect health (i.e. EQ-5D-5L utility = 1). The second
part applied OLS regression in one two-part model and
binomial beta regression in another two-part model to
utilities less than 1. Binomial beta regression was per-
formed because of its ability to deal with left and right
skewed HRQoL data [28]. The dependent variable in the
binomial beta regression was specified similar to the
fractional logistic regression.
Response mapping models
Several models have been proposed in the literature to
predict responses to EQ-5D dimensions [22], the most
frequently used are multinomial and ordinal logistic regres-
sions [21]. A multinomial logit and an ordinal logit were
specified to estimate responses based on the expected value
method [22, 29]. These regression models were applied to
each dimension of the EQ-5D-5L and used to calculate the
probabilities of responding to each of the five levels. The
expected dis-utilities (inverse of utility) in each dimension
were calculated by using the estimated response probabil-
ities and the EQ-5D-5L UK valuation set [15].
Assessment of model performance
Predicted EQ-5D-5L utilities were estimated for each
mapping model with back-transformation applied to the
GLM models, fractional logistic regression, and binomial
beta regression. For the two-part models, expected utility
was estimated as:
Utility ¼ Pr Utility ¼ 1ð Þ
þ ð1 − Pr Utility ¼ 1ð ÞU ð2Þ
where U is the utility conditional on imperfect health
(i.e. < 1) estimated in the second part of the models.
The mapping models were compared in terms of their
ability to accurately predict EQ-5D-5L utility based on
common metrics of predictive performance. Mean
squared error (MSE) indicated goodness-of-fit and mean
absolute error (MAE) measured individual-level predic-
tion accuracy. These metrics were calculated in the esti-
mation sample as well as in the two external validation
models separately and jointly. Scatterplots with the ob-
served and predicted EQ-5D-5L and EQ-5D-3L utility
were created for each mapping model.
After the best performing model was selected, we in-
vestigated whether it performed equally well across dif-
ferent levels of morbidity and between males and
females. This was done by plotting MSE across the dec-
iles of the DBIS Score by gender. This was done using
only the original LTCQ validation dataset because the
DBIS Score was not available in the other two datasets.
Results
The mean EQ-5D-5L utility in the dataset from the valid-
ation study of the LTCQ was 0.616 (SD: 0.320). A similar
mean utility was recorded in the baseline dataset from the
Feeling Safe study among a sample with mental health con-
ditions (mean: 0.605, SD: 0.219) and a higher utility recorded
in the sample with dementia or mild cognitive impairment
from the additional validation of the LTCQ (mean: 0.785,
SD: 0.205). In our combined estimation sample of 1001 par-
ticipants from across the datasets, the mean score was 0.623
(SD: 0.312). The mean DBIS score, only recorded for the full
LTCQ validation sample, was 15.936 (SD: 12.814).
Table 2 provides the responses for the EQ-5D-5L and
LTCQ-8 questions by dataset. Figure 1 provides the
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distribution of scores on the EQ-5D-5L and the EQ-5D-
3L by dataset. This illustrates the bounded and skewed
distribution of the utilities.
















No Problems 367 (32%) 61 (53%) 48 (52%) 360 (36%)
Slight Problems 202 (18%) 23 (20%) 13 (14%) 176 (18%)
Moderate Problems 223 (20%) 20 (17%) 24 (26%) 200 (20%)
Severe problems 231 (21%) 10 (9%) 8 (8%) 185 (19%)
Unable 103 (9%) 1 (1%) 0 (0%) 80 (8%)
EQ-5D Self-care
No Problems 655 (58%) 62 (54%) 71 (77%) 593 (59%)
Slight Problems 154 (14%) 23 (20%) 13 (14%) 142 (14%)
Moderate Problems 144 (13%) 23 (20%) 3 (3%) 126 (13%)
Severe problems 83 (7%) 7 (6%) 4 (4%) 68 (7%)
Unable 90 (8%) 0 (0%) 2 (2%) 72 (7%)
EQ-5D Usual activities
No Problems 352 (31%) 18 (16%) 50 (54%) 311 (31%)
Slight Problems 236 (21%) 27 (24%) 17 (18%) 206 (21%)
Moderate Problems 245 (22%) 42 (37%) 17 (18%) 232 (23%)
Severe problems 152 (14%) 22 (19%) 5 (6%) 135 (13%)
Unable 141 (12%) 5 (5%) 4 (4%) 117 (12%)
EQ-5D Pain/Discomfort
No Problems 258 (23%) 38 (33%) 42 (45%) 256 (25%)
Slight Problems 331 (29%) 31 (27%) 22 (24%) 290 (29%)
Moderate Problems 294 (26%) 33 (28%) 25 (27%) 266 (26%)
Severe problems 183 (16%) 12 (10%) 3 (3%) 146 (15%)
Unable 60 (5%) 1 (1%) 1 (1%) 43 (4%)
EQ-5D Anxiety/depression Anxiety/Depression
No Problems 471 (42%) 5 (4%) 37 (40%) 396 (40%)
Slight Problems 301 (27%) 17 (15%) 32 (34%) 247 (25%)
Moderate Problems 232 (20%) 49 (43%) 20 (22%) 224 (22%)
Severe problems 77 (7%) 29 (25%) 4 (4%) 90 (9%)
Unable 45 (4%) 15 (13%) 0 (0%) 44 (4%)
LTCQ4. Control of daily life
Never 94 (8%) 9 (8%) 3 (3%) 83 (8%)
Rarely 142 (13%) 51 (44%) 9 (10%) 140 (14%)
Sometimes 242 (21%) 36 (31%) 22 (24%) 232 (23%)
Often 236 (21%) 19 (17%) 17 (18%) 205 (20%)
Always 412 (37%) 0 (0%) 42 (45%) 341 (34%)
LTCQ7. Safe at home
Never 19 (2%) 4 (4%) 2 (2%) 18 (2%)
Rarely 38 (3%) 24 (21%) 1 (1%) 49 (5%)
Sometimes 109 (10%) 43 (37%) 3 (3%) 120 (12%)
Often 212 (19%) 31 (27%) 14 (15%) 188 (19%)
Always 748 (66%) 13 (11%) 73 (79%) 626 (62%)
















LTCQ8. Safe outside home
Never 95 (8%) 20 (17%) 7 (8%) 86 (8%)
Rarely 116 (11%) 44 (38%) 7 (8%) 128 (13%)
Sometimes 251 (22%) 35 (30%) 15 (16%) 227 (23%)
Often 212 (19%) 10 (9%) 20 (21%) 174 (17%)
Always 452 (40%) 6 (5%) 44 (47%) 386 (38%)
LTCQ10. Dependant
Always 292 (26%) 17 (15%) 12 (13%) 242 (24%)
Often 224 (20%) 49 (43%) 28 (30%) 228 (23%)
Sometimes 226 (20%) 32 (28%) 25 (27%) 215 (21%)
Rarely 155 (14%) 13 (11%) 16 (17%) 131 (13%)
Never 229 (20%) 4 (3%) 2 (13%) 185 (18%)
LTCQ11. Lonely
Always 126 (11%) 39 (34%) 5 (5%) 133 (13%)
Often 162 (14%) 40 (35%) 11 (12%) 155 (15%)
Sometimes 264 (23%) 24 (21%) 20 (22%) 233 (23%)
Rarely 167 (15%) 4 (4%) 15 (16%) 131 (13%)
Never 407 (36%) 8 (7%) 42 (45%) 349 (35%)
LTCQ12. Stigma
Always 77 (7%) 28 (24%) 3 (3%) 77 (8%)
Often 116 (10%) 44 (38%) 21 (23%) 121 (12%)
Sometimes 281 (25%) 30 (26%) 22 (24%) 243 (24%)
Rarely 198 (18%) 10 (9%) 47 (50%) 182 (18%)
Never 454 (40%) 3 (3%) 0 (0%) 378 (38%)
LTCQ15. Unhappy
Always 148 (13%) 31 (27%) 4 (4%) 139 (14%)
Often 203 (18%) 48 (42%) 14 (15%) 195 (19%)
Sometimes 350 (31%) 28 (24%) 33 (35%) 301 (30%)
Rarely 185 (17%) 5 (4%) 22 (24%) 164 (16%)
Never 240 (21%) 3 (3%) 20 (22%) 202 (20%)
LTCQ19. Confident
Never 59 (5%) 5 (4%) 6 (6%) 53 (5%)
Rarely 84 (8%) 27 (24%) 2 (2%) 82 (8%)
Sometimes 254 (23%) 60 (52%) 17 (18%) 252 (25%)
Often 252 (22%) 18 (16%) 25 (26%) 223 (22%)
Always 477 (42%) 5 (4%) 43 (46%) 391 (39%)
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Direct mapping
Table 3 shows the performance of the various models
when estimating EQ-5D-5L and EQ-5D-3L utilities
within the estimation dataset. The two-part model with
OLS was the best performing model based on the mean
squared error (0.038) and mean absolute error (0.147)
when estimating the EQ-5D-5L, as well for EQ-5D-3L
utilities (MSE: 0.052, MAE: 0.172). The order of rank
was largely consistent based on either the mean squared
error or mean absolute error and between utilities. The
mean squared error was consistently lower for the 5 L
utility compared to the 3 L. Of the possible response
mapping models, the multinomial logit was the better
performing (MSE: 0.045; MAE: 0.155).
Figure 2 shows the performance of the two-part OLS
model as measured by the mean squared error across
deciles of the DBIS scores. This confirms, as per Table
3, that the model performs better on the EQ-5D-5L
compared to the 3 L. It also shows that model perform-
ance deteriorates among those with higher DBIS scores,
representing high severity and/or multiple conditions,
especially among males.
Table 4 provides regression coefficients for the best
performing model, the two-part model with OLS. The
results can be used to estimate the EQ-5D utilities based
on a set of responses to the Short-Form LTCQ accord-
ing to Eq. 2:
Utility ¼ Pr Utility ¼ 1ð Þ
þ ð1 − Pr Utility ¼ 1ð ÞU ð2Þ
For instance, in a set of responses for an individual
responding “living well” throughout the LTCQ, the
Fig. 1 Distribution of EQ-5D-5L and EQ-5D-3L (using crosswalk) utility in each dataset
Table 3 Model performance based on the estimation sample (n = 1001)
EQ-5D-5L utility Model rank EQ-5D-3L utility Model rank
Model MSE (MAE) MSE MAE MSE (MAE) MSE MAE
1. OLS 0.0390 (0.1486) 2 2 0.0525 (0.1732) 2a 3
2. Tobit 0.0397 (0.1490) 4 3 0.0536 (0.1744) 5 5
3. CLAD 0.0436 (0.1566) 7 9 0.0574 (0.1808) 7 7
4. GLM (Gamma; Log link) 0.0414 (0.1515) 6 5 0.0540 (0.1742) 6 4
5. GLM (Gaussian; Log link) 0.0399 (0.1527) 5 6 0.0533 (0.1747) 4 6
6. Fractional logit 0.0392 (0.1492) 3 4 0.0525 (0.1724) 2a 2
7. Two-part model with OLS 0.0384 (0.1474) 1 1 0.0516 (0.1716) 1 1
8. Two-part model with beta regression 0.0473 (0.1575) 10 10 0.0903 (0.2157) 10 10
9. Multinomial logit 0.0451 (0.1550) 8 7 0.0675 (0.1972) 8 8
10. Ordered logit 0.0458 (0.1563) 9 8 0.0705 (0.1999) 9 9
OLS Ordinary Least Square, GLM Generalised Linear Model, MSE Mean Squared Error, MAE Mean Absolute Error
atied
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probability of being in perfect health (utility of 1) is
given by the sum of the constant and the coefficients
for “living well” across each domain for part 1 – note,
this needs to be transformed by taking the inverse of
the logistic function. The predicted second-part utility
is given by the sum of the constant and respective
domain coefficients from the part 2 estimates. Finally,
the predicted EQ-5D utility is given by substituting
the above values into Eq. 2, producing a utility esti-
mate of 0.93 for the EQ-5D-5L (see Appendix 2 for a
detailed calculation).
Out-of-sample prediction
When we fitted the coefficients to the validation sample
(n = 333), the mean predicted EQ-5D-5L utility from the
two-part OLS model was 0.64 (SD: 0.25), compared to
the recorded mean of 0.63 (SD: 0.30). The mean pre-
dicted EQ-5D-3L was 0.55 (SD: 0.28), compared to a re-
corded 0.53 (SD: 0.34). The mean squared error of our
predicted value was 0.040 for the EQ. 5D-5L and 0.0582
for the EQ. 5D-3L; the mean absolute error was 0.1520
and 0.1848, respectively.
Response mapping
Appendix 3 reports the multinomial logit results for
each of the EQ-5D questions with the 8 items of the
short-form LTCQ as the predictor variables. The Mc-
Fadden pseudo-R2 indicates that the models perform
fairly well, particularly in the self-care, usual activity and
anxiety/depression domains. The results were broadly
intuitive. In several instances, the result for a given
LTCQ-8 question most related to an EQ-5D domain is
significant; for example, the LTCQ-8 question on feeling
dependent is significant across a number of EQ-5D do-
mains but particularly for usual activities and less so for
anxiety and depression.
Discussion
This study provides a mapping algorithm for estimating
EQ-5D utilities from LTCQ-8 responses. We have
shown that our approach produces estimated utility
scores that closely approximate what would have been
recorded had the EQ-5D been administered, particularly
for individuals outside of the most severe health states.
The results from this study can help extend the applic-
ability of the LTCQ by estimating utility values for use
in economic analyses.
In this paper, we presented a broad range of poten-
tial models. Consistent with previous studies, a simple
OLS model performed well for predicting average
utilities, but the two-part model with OLS emerged
as the best-performing model. The two-part model
was proposed to better reflect the bounded nature of
EQ-5D scores. The mean squared errors and mean
absolute errors recorded in our models were similar
to that reported elsewhere [30]. The small differences
Fig. 2 Mean Squared Errors across deciles of the DBIS score by gender based on the LTCQ validation dataset (n = 1126). Notes: Bars show the
standard deviation of the mean Mean Squared Error in each decile; Dashed lines show the outer fence of 2 standard deviations from the mean
Mean Squared Error in each decile; Dots show outliers with Mean Squared Error larger than one Standard Deviation of the mean Mean Squared
Error in each decile
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in performance between several models is consistent
with research elsewhere [22, 31], as well as with the
finding that the validity of mapping algorithms is
more strongly a function of the particular instrument
and disease or patient group rather than the specific
technique employed [32].
We mapped our results onto both EQ-5D-5L and
EQ-5D-3L utilities. The NICE position statement from
November 2018 affirms the present need to use the
EQ-5D-3L for reference-case analyses and recom-
mends mapping to the EQ-5D-3L if EQ-5D-5L data
had been collected [12]. EQ-5D-3L values in this study
were thus derived using the recommended crosswalk
[16]. Our models performed better on the EQ. 5D-5L
than the 3 L, implying that the greater sensitivity
afforded by the additional levels in the EQ-5D-5L
helped achieve improved model fit.
In addition, we mapped a response model (multi-
nomial logit) that indicates how responses to questions
from the LTCQ-8 impact across the dimensions of the
EQ-5D-5L. This mainly provided intuitive results, with
responses to particular questions affecting appropriate
domains. For instance, feeling more in control of daily
life was significantly associated with being in a less se-
vere state in the mobility domain. Although, there were
also some seemingly counter-intuitive signs, for instance
‘always feeling safe at home’ was a positive and significant
predictor of being in the most severe state in the mobility
domain relative to the least severe. Albeit, this could re-
flect the person being in adjusted accommodation where
they do feel safe. A larger validation dataset would help to
clarify this.
Similarly, a validation dataset with more severe
health states (lower utilities) would help assess
model performance where it was weakest, although
worsening predictive performance for patients in se-
vere states is consistent with other research [30].
Similarly, since utilities are often required for spe-
cific subgroups of patients, further validation could
occur with populations dissimilar from those fea-
tured in this paper.
Conclusions
As a result of the mapping algorithm produced in this
study, surveys that include the LTCQ, or the short form
LTCQ-8, can now be used to estimate utility values for
economic analyses. Although the existence of a mapping
algorithm is not an argument against the inclusion of
direct preference-based measures in prospective studies
- mapping is a second-best solution to direct measure-
ment [33] - the ability to generate estimated utilities
should increase the potential of the LTCQ for use as a
comprehensive outcome measure for evaluating inte-
grated care initiatives.
Table 4 Regression coefficients for the best model: two-part
with OLS
EQ 5D-5L utilities EQ 5D-3L utilities
using crosswalk
Part 1- Logit Part 2- OLS Part 2- OLS
Reference category
in brackets
Odds Ratio (se) b (se) b (se)
LTCQ4. Control of daily life (Never)
Rarely 1.240 (2.0123) 0.167 (0.030)* 0.220 (0.034)*
Sometimes −0.448 (2.091) 0.174 (0.030)* 0.233 (0.034)*
Often −0.045 (1.866) 0.209 (0.034)* 0.273 (0.039)*
Always 1.145 (1.831) 0.235 (0.037)* 0.286 (0.042)*
LTCQ7. Safe at home (Never)
Rarely −31.701 (3435.388) 0.017 (0.060) 0.027 (0.068)
Sometimes −31.103 (3295.443) −0.016 (0.056) − 0.017 (0.064)
Often −16.537 (1488.793) −0.031 (0.056) − 0.033 (0.064)
Always −17.518 (1488.793) 0.014 (0.056) −0.010 (0.064)
LTCQ8. Safe outside home (Never)
Rarely −0.674 (2939.661) 0.013 (0.031) 0.010 (0.035)
Sometimes 14.568 (1488.792) 0.191 (0.023) 0.075 (0.034)*
Often 13.895 (1488.792) 0.225 (0.028)* 0.109 (0.038)*
Always 15.067 (1488.792) 0.235 (0.029)* 0.166 (0.039)*
LTCQ10. Dependant (Always)
Often −0.738 (0.842) 0.138 (0.021)* 0.162 (0.024)*
Sometimes −0.483 (0.611) 0.191 (0.023)* 0.221 (0.026)*
Rarely 0.070 (0.616) 0.225 (0.028)* 0.258 (0.032)*
Never 0.263 (0.587) 0.235 (0.029)* 0.268 (0.033)*
LTCQ11. Lonely (Always)
Often 0.015 (1.017) −0.028 (0.028) −0.016 (0.031)
Sometimes −1.439 (0.920) −0.035 (0.028) −0.030 (0.032)
Rarely −0.915 (0.814) −0.015 (0.032) − 0.006 (0.036)
Never −0.410 (0.700) − 0.024 (0.031) − 0.016 (0.036)
LTCQ12. Stigma (Always)
Often −26.818 (2169.424) −0.017 (0.032) −0.002 (0.036)
Sometimes −0.516 (1.373) − 0.033 (0.031) − 0.009 (0.035)
Rarely −0.737 (1.366) 0.006 (0.033) 0.020 (0.037)
Never −0.845 (1.337) −0.034 (0.033) − 0.020 (0.038)
LTCQ15. Unhappy (Always)
Often 16.502 (2105.194) 0.084 (0.025)* 0.084 (0.028)*
Sometimes 17.163 (2105.194) 0.149 (0.027)* 0.138 (0.031)*
Rarely 18.324 (2105.194) 0.155 (0.032)* 0.121 (0.037)*
Never 18.952 (2105.194) 0.152 (0.033)* 0.140 (0.039)*
LTCQ19. Confident (Never)
Rarely −15.296 (3063.957) 0.020 (0.038) 0.014 (0.043)
Sometimes −1.553 (1.622) 0.018 (0.035) 0.034 (0.040)
Often −0.167 (1.169) 0.034 (0.038) 0.062 (0.043)
Always 0.315 (1.082) 0.070 (0.039) 0.120 (0.044)*
Constant −16.994 (2105.193) 0.061 (0.058) −0.130 (0.066)*
n 1001 896 896
SE standard error
* p-value< 0.005
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Appendix 2
Estimating utilities based on responses to the short form LTCQ
EQ 5D utilities can be estimated for the best-fitting
model according to Eq. 2:
Utility ¼ Pr Utility ¼ 1ð Þ
þ ð1 − Pr Utility ¼ 1ð ÞU ð2Þ
Based on Table 3, the utility for someone responding
“living well” throughout the survey is estimated as follows:
Part one estimate
To estimate the probability of being in perfect health,
we sum the constant and domain coefficients and use the
inverse of the logistic function to re-transform the data.
The inverse logistic function is exp(x)/(1 + exp (x)) and
can be calculated using the Stata command “invlogit”.
Pr Utility ¼ 1ð Þ ¼ InvLogitð b Constant½ 
þ b Control½  þ b Safe at home½ 
þ b Safe outside home½ 
þ b Dependant½  þ b Lonely½ 
þ b Stigma½  þ b Unhappy½ 
þ b Confident½ 
Pr(Utility = 1) = InvLogit( − 17.0 + 1.1 + 17.2 + 15.1 +
0.3 ± 0.4 ± 0.8 + 18.6 + 0.3) = 0.49.
Part two estimate
U ¼ ð b Constant½  þ b Control½  þ b Safe at home½ 
þ b Safe outside home½  þ b Dependant½ 
þ b Lonely½  þ b Stigma½  þ b Unhappy½ 
þ b Confident½ 
U = (0.06 + 0.24 + 0.01 + 0.16 + 0.23 + − 0.02 + − 0.03 +
0.15 + 0.07) = 0.87
Overall utility estimate
Utility = Pr(Utility = 1) + (1 − Pr(Utility = 1) ∗U =0.49 +
((1 − 0.49) ∗ 0.87) = 0.93
Appendix 1
Fig. 3 Scatter plots of the observed EQ-5D-5L utility versus predicted EQ-5D-5 L utility
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Appendix 3
Table 5 Response mapping model of LTCQ fitted using multinomial logistic regression
L1 (No
Problems)
L2 vs L1 L3 vs L1 L4 vs L1 L5 vs L1
Slight Problems Moderate Problems Severe Problems Unable
Mobility
LTCQ4. Control of daily life (Never)
Rarely 0.669 (0.913) −0.779 (0.635) −1.97 (0.591)* −2.85 (0.664)*
Sometimes 0.92 (0.917) −0.358 (0.638) −1.542 (0.598)* −2.064 (0.652)*
Often 1.253 (0.935) −0.981 (0.677) −1.581 (0.645)* −2.67 (0.762)*
Always 0.9 (0.944) −1.407 (0.705)* −2.441 (0.696)* −2.752 (0.811)*
LTCQ7. Safe at home (Never)
Rarely 1.376 (1.277) 1.058 (1.002) −0.488 (0.858) −0.718 (1.168)
Sometimes 1.158 (1.252) 1.065 (0.978) 0.396 (0.796) 1.181 (1.025)
Often 1.718 (1.245) 1.381 (0.98) 1.073 (0.801) 2.057 (1.036)*
Always 1.713 (1.248) 1.769 (0.982) 0.526 (0.806) 2.121 (1.038)*
LTCQ8. Safe outside home (Never)
Rarely −0.357 (0.671) −0.488 (0.578) − 0.689 (0.562) − 0.976 (0.66)
Sometimes − 0.429 (0.641) − 0.628 (0.567) −1.457 (0.556)* −1.449 (0.639)*
Often − 0.927 (0.684) −1.095 (0.615) −2.633 (0.632)* −1.611 (0.727)*
Always −1.544 (0.679)* −2.213 (0.625)* −3.044 (0.626)* −3.306 (0.754)*
LTCQ10. Dependant (Always)
Often 0.405 (0.419) 0.226 (0.339) −1.177 (0.335)* −1.791 (0.439)*
Sometimes 0.582 (0.411) −0.182 (0.35) −1.599 (0.362)* −2.667 (0.551)*
Rarely 0.349 (0.435) −1.099 (0.424)* −3.279 (0.608)* −3.424 (0.829)*
Never −0.197 (0.448) −2.724 (0.548)* −3.998 (0.654)* −4.935 (1.116)*
LTCQ11. Lonely (Always)
Often 0.38 (0.464) 0.379 (0.402) 0.685 (0.432) −0.26 (0.567)
Sometimes 0.574 (0.463) 0.281 (0.42) 1.205 (0.445)* 0.684 (0.542)
Rarely 0.69 (0.501) 0.504 (0.468) 1.534 (0.516)* 0.871 (0.654)
Never 0.778 (0.478) 0.733 (0.447) 1.388 (0.512)* 0.974 (0.651)
LTCQ12. Stigma (Always)
Often −0.362 (0.554) 0.207 (0.509) 0.416 (0.501) 0.661 (0.604)
Sometimes −0.429 (0.533) 0.414 (0.494) 0.915 (0.487) 0.709 (0.585)
Rarely −0.495 (0.55) 0.373 (0.516) 0.154 (0.537) 0.352 (0.655)
Never 0.028 (0.55) 0.884 (0.530) 1.142 (0.550)* 0.688 (0.668)
LTCQ15. Unhappy (Always)
Often −0.218 (0.46) −0.392 (0.400) − 0.465 (0.408) − 0.397 (0.509)
Sometimes 0.182 (0.474) 0.139 (0.425) −0.674 (0.449) − 0.443 (0.577)
Rarely −0.363 (0.524) −0.42 (0.510) − 0.49 (0.544) 0.649 (0.694)
Never −0.186 (0.527) 0.238 (0.509) −0.377 (0.577) − 0.332 (0.829)
LTCQ19. Confident (Never)
Rarely −1.282 (0.748) −0.628 (0.722) − 0.475 (0.722) − 0.215 (0.788)
Sometimes − 1.711 (0.691)* − 0.823 (0.681) − 0.066 (0.684) − 0.415 (0.75)
Often − 1.588 (0.71)* − 0.564 (0.708) 0.256 (0.721) −1.098 (0.834)
Always −1.866 (0.706)* − 1.147 (0.718) − 0.143 (0.739) − 1.011 (0.843)
Constant − 1.031 (1.428) 0.56 (1.123) 2.796 (0.947)* 2.424 (1.114)*
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Table 5 Response mapping model of LTCQ fitted using multinomial logistic regression (Continued)
L1 (No
Problems)
L2 vs L1 L3 vs L1 L4 vs L1 L5 vs L1
Slight Problems Moderate Problems Severe Problems Unable
Self-care
LTCQ4. Control of daily life (Never)
Rarely −1.097 (0.664) −1.309 (0.615)* − 1.970 (0.640)* − 2.689 (0.643)*
Sometimes − 1.038 (0.653) − 1.539 (0.615)* − 2.239 (0.640)* − 2.919 (0.649)*
Often − 1.354 (0.688)* − 2.537 (0.691)* − 2.767 (0.776)* −3.368 (0.735)*
Always − 1.889 (0.757)* − 2.055 (0.732)* − 4.186 (1.037)* −3.548 (0.819)*
LTCQ7. Safe at home (Never)
Rarely −0.416 (0.878) 1.185 (0.957) 0.423 (1.092) −0.113 (1.172)
Sometimes − 0.269 (0.812) 0.209 (0.928) 1.47 (0.993) 0.877 (1.052)
Often −0.345 (0.811) 0.988 (0.91) 1.347 (1.006) 1.065 (1.058)
Always −0.558 (0.815) 0.733 (0.918) 1.462 (1.004) 0.914 (1.058)
LTCQ8. Safe outside home (Never)
Rarely 0.297 (0.546) −0.653 (0.500) −0.335 (0.579) − 0.391 (0.592)
Sometimes 0.151 (0.527) −0.936 (0.478)* −0.878 (0.568) − 0.917 (0.567)
Often −0.593 (0.578) − 0.914 (0.531) −1.362 (0.750) − 0.822 (0.654)
Always −1.335 (0.616)* −2.352 (0.605)* −1.828 (0.740)* − 1.902 (0.680)*
LTCQ10. Dependant (Always)
Often 0.074 (0.309) −0.534 (0.307) −1.301 (0.420)* −1.699 (0.421)*
Sometimes −0.347 (0.331) −1.345 (0.365)* −1.479 (0.489)* −2.661 (0.596)*
Rarely −1.176 (0.460)* −3.128 (0.783)* −15.851 (619.704) −2.987 (0.817)*
Never −2.646 (0.803)* −3.201 (0.831)* −2.136 (0.864)* −4.182 (1.131)*
LTCQ11. Lonely (Always)
Often −0.138 (0.4) 0.817 (0.441) −0.068 (0.543) 0.053 (0.556)
Sometimes 0.048 (0.409) 0.775 (0.466) 0.665 (0.538) 0.243 (0.554)
Rarely −0.014 (0.464) −0.013 (0.569) − 0.123 (0.705) 0.160 (0.659)
Never 0.138 (0.476) 0.974 (0.538) −0.504 (0.806) 0.652 (0.662)
LTCQ12. Stigma (Always)
Often 0.675 (0.495) 0.532 (0.503) −0.159 (0.575) 0.291 (0.601)
Sometimes 0.56 (0.487) 0.345 (0.491) 0.046 (0.544) 0.418 (0.570)
Rarely 0.373 (0.515) 0.212 (0.528) −1.226 (0.730) 0.081 (0.648)
Never 0.658 (0.533) 0.014 (0.564) −0.507 (0.693) 0.163 (0.661)
LTCQ15. Unhappy (Always)
Often −0.385 (0.375) −0.412 (0.391) − 0.269 (0.477) 0.087 (0.488)
Sometimes −0.258 (0.399) −0.151 (0.426) 0.026 (0.542) −0.026 (0.549)
Rarely −0.002 (0.504) −0.056 (0.586) 1.027 (0.764) 0.884 (0.705)
Never 0.06 (0.542) 0.029 (0.610) 1.292 (0.883) −1.618 (1.190)
LTCQ19. Confident (Never)
Rarely 0.67 (0.818) −0.402 (0.676) −0.049 (0.708) − 0.686 (0.737)
Sometimes 0.446 (0.771) −0.615 (0.617) −1.111 (0.676) −1.128 (0.673)
Often 0.35 (0.795) −0.882 (0.651) −1.97 (0.798)* − 1.176 (0.73)
Always −0.016 (0.821) −1.121 (0.679) − 1.887 (0.822)* − 0.986 (0.767)
Constant 0.613 (1.095) 1.801 (1.044) 2.362 (1.072)* 2.893 (1.119)*
Usual activities
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Table 5 Response mapping model of LTCQ fitted using multinomial logistic regression (Continued)
L1 (No
Problems)
L2 vs L1 L3 vs L1 L4 vs L1 L5 vs L1
Slight Problems Moderate Problems Severe Problems Unable
LTCQ4. Control of daily life (Never)
Rarely 1.007 (1.102) 1.22 (0.964) −0.325 (0.888) −1.517 (0.894)
Sometimes 0.842 (1.015) 0.869 (0.882) −1.009 (0.801) −2.246 (0.811)*
Often 0.262 (1.018) 0.201 (0.893) −1.655 (0.829)* −3.144 (0.882)*
Always −0.022 (1.022) − 0.538 (0.911) −3.052 (0.906)* − 3.369 (0.903)*
LTCQ7. Safe at home (Never)
Rarely 0.87 (1.439) 1.434 (1.29) 1.463 (1.322) 1.116 (1.394)
Sometimes 0.972 (1.262) 1.251 (1.126) 1.524 (1.147) 2.322 (1.195)
Often 0.756 (1.226) 1.075 (1.09) 1.978 (1.111) 2.527 (1.167)*
Always 0.486 (1.216) 0.856 (1.077) 1.512 (1.099) 2.432 (1.153)*
LTCQ8. Safe outside home (Never)
Rarely 0.606 (1.05) 1.295 (0.985) 0.395 (0.986) 0.094 (1.004)
Sometimes −0.431 (0.778) −0.256 (0.719) −1.34 (0.718) −1.631 (0.74)*
Often 0.009 (0.801) −0.389 (0.751) −1.811 (0.781)* −2.028 (0.835)*
Always −0.736 (0.789) −1.309 (0.74) − 2.896 (0.788)* −3.197 (0.804)*
LTCQ10. Dependant (Always)
Often 0.645 (0.462) 0.516 (0.432) −0.308 (0.457) −1.145 (0.497)*
Sometimes 0.276 (0.42) − 0.096 (0.394) −1.372 (0.469)* −2.302 (0.571)*
Rarely −0.123 (0.446) −1.684 (0.481)* −2.200 (0.603)* −3.700 (1.091)*
Never −0.562 (0.461) −2.276 (0.550)* − 1.996 (0.650)* −3.221 (0.811)*
LTCQ11. Lonely (Always)
Often 0.097 (0.588) −0.419 (0.53) 0.328 (0.581) 0.340 (0.634)
Sometimes 1.097 (0.561) 0.234 (0.517) 1.015 (0.584) 1.218 (0.629)
Rarely 1.349 (0.587)* 0.4 (0.55) 0.152 (0.724) 0.931 (0.728)
Never 1.289 (0.566)* 0.627 (0.521) 1.732 (0.641)* 0.806 (0.735)
LTCQ12. Stigma (Always)
Often 0.307 (0.698) −0.466 (0.646) 0.432 (0.688) −0.258 (0.722)
Sometimes 0.742 (0.662) 0.629 (0.605) 1.159 (0.663) 0.647 (0.682)
Rarely 0.529 (0.67) 0.592 (0.624) 0.556 (0.713) 0.692 (0.737)
Never 0.38 (0.665) 0.948 (0.615) 0.989 (0.719) 0.966 (0.751)
LTCQ15. Unhappy (Always)
Often −0.507 (0.633) −0.286 (0.597) − 0.469 (0.622) − 0.388 (0.658)
Sometimes − 0.824 (0.604) − 1.037 (0.578) − 1.341 (0.621)* − 1.208 (0.676)
Rarely − 1.262 (0.631)* − 1.631 (0.632)* − 1.780 (0.741)* − 1.004 (0.81)
Never − 1.654 (0.640)* − 1.415 (0.631)* −2.019 (0.770)* − 1.320 (0.865)
LTCQ19. Confident (Never)
Rarely 0.496 (1.162) 0.221 (0.974) 0.144 (1.003) 0.283 (0.993)
Sometimes 0.950 (1.014) 0.087 (0.825) 0.573 (0.86) −0.361 (0.863)
Often 0.860 (1.014) 0.145 (0.826) 0.45 (0.879) −0.633 (0.9)
Always 0.323 (1.003) −0.675 (0.814) − 0.342 (0.881) −1.223 (0.894)
Constant −1.638 (1.561) 0.300 (1.272) 1.448 (1.218) 2.872 (1.221)*
Pain and discomfort
LTCQ4. Control of daily life (Never)
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Table 5 Response mapping model of LTCQ fitted using multinomial logistic regression (Continued)
L1 (No
Problems)
L2 vs L1 L3 vs L1 L4 vs L1 L5 vs L1
Slight Problems Moderate Problems Severe Problems Unable
Rarely −0.796 (0.665) −1.903 (0.617)* −1.005 (0.643) −3.207 (0.795)*
Sometimes −0.645 (0.666) −1.123 (0.613) −0.358 (0.65) − 1.793 (0.748)*
Often −0.698 (0.697) −1.206 (0.653) − 0.97 (0.724) − 1.766 (0.888)*
Always −0.997 (0.708) −1.736 (0.671)* − 1.216 (0.78) − 1.557 (1.177)
LTCQ7. Safe at home (Never)
Rarely −0.203 (1.396) −1.136 (1.252) − 0.105 (1.284) − 0.596 (1.457)
Sometimes −0.675 (1.323) −1.88 (1.18) − 1.025 (1.224) − 0.978 (1.371)
Often − 1.004 (1.319) − 1.888 (1.173) − 0.903 (1.218) −1.094 (1.401)
Always − 0.573 (1.323) −1.758 (1.18) −1.401 (1.233) − 1.433 (1.41)
LTCQ8. Safe outside home (Never)
Rarely − 0.331 (0.551) −0.432 (0.536) − 0.35 (0.537) 0.309 (0.752)
Sometimes −0.374 (0.526) −0.258 (0.513) − 0.47 (0.525) 0.135 (0.752)
Often −0.373 (0.567) − 0.442 (0.56) − 0.675 (0.605) 0.252 (0.933)
Always −0.751 (0.563) − 0.595 (0.561) −1.172 (0.637)* −1.409 (1.145)
LTCQ10. Dependant (Always)
Often 0.29 (0.345) −0.050 (0.329) −0.368 (0.348) −1.664 (0.578)*
Sometimes − 0.16 (0.338) −0.715 (0.330)* −1.278 (0.391)* −2.034 (0.74)*
Rarely 0.22 (0.374) −0.890 (0.394)* − 0.939 (0.483) − 15.902 (863.068)
Never 0.208 (0.377) −1.286 (0.411)* − 1.41 (0.567)* −0.96 (1.069)
LTCQ11. Lonely (Always)
Often −0.301 (0.417) − 0.083 (0.433) 0.447 (0.433) 0.723 (0.658)
Sometimes −0.232 (0.415) 0.835 (0.430) 0.55 (0.466) 1.048 (0.699)
Rarely 0.075 (0.453) 1.126 (0.482)* 0.575 (0.562) −12.693 (565.764)
Never − 0.775 (0.418) 0.672 (0.457) 0.478 (0.535) 1.103 (0.958)
LTCQ12. Stigma (Always)
Often 0.109 (0.514) 0.618 (0.499) 0.047 (0.504) −0.667 (0.665)
Sometimes 0.819 (0.493) 1.057 (0.494)* 0.952 (0.5) −0.035 (0.636)
Rarely 0.445 (0.504) 0.722 (0.511) 0.519 (0.544) −1.073 (0.855)
Never 0.864 (0.51) 1.128 (0.520)* 1.356 (0.56) −0.701 (0.909)
LTCQ15. Unhappy (Always)
Often 0.463 (0.45) 0.140 (0.412) −0.329 (0.409) −1.389 (0.587)*
Sometimes 0.965 (0.463)* −0.011 (0.437) −1.007 (0.458)* −1.479 (0.692)*
Rarely 0.71 (0.498) −0.793 (0.494) −2.147 (0.637)* −2.276 (1.27)
Never −0.045 (0.504) −1.414 (0.502)* − 1.878 (0.590)* − 2.574 (1.326)
LTCQ19. Confident (Never)
Rarely −0.749 (0.711) −0.479 (0.679) − 0.15 (0.712) −0.01 (0.868)
Sometimes −0.97 (0.642) −0.676 (0.622) − 0.001 (0.659) 0.073 (0.83)
Often 0.136 (0.665) −0.02 (0.654) 0.624 (0.708) 1.119 (0.967)
Always −0.508 (0.654) −0.602 (0.643) − 0.067 (0.721) − 1.796 (1.399)
Constant 1.786 (1.423) 3.638 (1.284)* 2.502 (1.341) 3.501 (1.451)*
Anxiety and depression
LTCQ4. Control of daily life (Never)
Rarely 1.227 (0.625)* 0.848 (0.597) 1.958 (0.683)* 1.642 (0.736)*
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Table 5 Response mapping model of LTCQ fitted using multinomial logistic regression (Continued)
L1 (No
Problems)
L2 vs L1 L3 vs L1 L4 vs L1 L5 vs L1
Slight Problems Moderate Problems Severe Problems Unable
Sometimes 0.496 (0.563) 0.165 (0.53) 0.907 (0.64) 0.167 (0.759)
Often 0.563 (0.585) 0.016 (0.574) 0.708 (0.744) 0.162 (1.08)
Always 0.135 (0.598) −1.225 (0.638) − 1.833 (1.281) 0.743 (1.227)
LTCQ7. Safe at home (Never)
Rarely −2.398 (1.624) −1.545 (1.606) −0.767 (1.689) −1.716 (1.694)
Sometimes −2.161 (1.505) −1.507 (1.523) −0.94 (1.61) −1.289 (1.603)
Often −2.377 (1.474) −1.526 (1.501) −1.224 (1.596) −2.486 (1.626)
Always −2.495 (1.469) −2.34 (1.5) −1.682 (1.6) − 2.846 (1.647)
LTCQ8. Safe outside home (Never)
Rarely 0.996 (0.61) 1.558 (0.595)* 1.391 (0.663)* 1.701 (0.726)*
Sometimes 1.017 (0.522) 0.857 (0.526) 0.558 (0.605) −0.316 (0.744)
Often 0.658 (0.538) 0.737 (0.57) 0.035 (0.746) −1.057 (1.265)
Always 0.931 (0.543) 1.637 (0.593)* 0.987 (0.806) 0.249 (1.188)
LTCQ10. Dependant (Always)
Often −0.039 (0.341) 0.01 (0.363) 0.339 (0.445) 0.386 (0.547)
Sometimes −0.098 (0.344) 0.116 (0.379) 0.49 (0.499) 0.103 (0.733)
Rarely 0.275 (0.386) 0.039 (0.47) 0.233 (0.704) −0.571 (1.213)
Never 0.041 (0.402) 0.084 (0.531) 1.368 (0.812) −0.174 (1.27)
LTCQ11. Lonely (Always)
Often 0.912 (0.585) −0.537 (0.544) − 0.69 (0.598) − 0.887 (0.689)
Sometimes 0.694 (0.531) −1.033 (0.498)* − 1.236 (0.582)* − 1.826 (0.775)*
Rarely 0.501 (0.547) −1.182 (0.537)* −2.832 (0.904)* −1.817 (1.018)
Never −0.292 (0.536) −1.721 (0.53)* − 2.612 (0.79)* − 2.31 (1.049)*
LTCQ12. Stigma (Always)
Often 1.636 (0.675)* 1.297 (0.626)* 1.599 (0.683)* 1.797 (0.777)*
Sometimes 1.039 (0.575) 0.991 (0.523) 0.357 (0.612) 0.997 (0.738)
Rarely 1.12 (0.582) 0.289 (0.554) −0.038 (0.7) 0.61 (0.891)
Never 0.891 (0.585) 0.598 (0.558) 0.794 (0.698) 1.756 (0.92)
LTCQ15. Unhappy (Always)
Often −0.439 (0.566) −0.196 (0.54) − 0.981 (0.582) −1.431 (0.662)*
Sometimes −0.807 (0.528) −1.396 (0.522)* −2.372 (0.607)* −3.357 (0.858)*
Rarely −1.525 (0.559) −3.057 (0.64)* −4.473 (1.178)* − 3.361 (1.049)*
Never −2.465 (0.586) −2.705 (0.642)* −4.287 (1.225)* −16.266 (421.364)
LTCQ19. Confident (Never)
Rarely 0.793 (0.843) 1.558 (0.819) 0.476 (0.894) 0.554 (0.934)
Sometimes −0.016 (0.679) 0.778 (0.66) 0.196 (0.731) 0.207 (0.787)
Often 0.072 (0.691) 0.548 (0.686) −0.163 (0.796) −0.574 (1.005)
Always −0.048 (0.69) −0.141 (0.701) − 0.978 (0.888) −2.179 (1.41)
Constant 0.817 (1.527) 2.121 (1.517) 1.725 (1.604) 2.469 (1.588)
* p-value< 0.005
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